I'm not sure about Diabetes, but they do target low-risk markets so it could be in the pipeline.
There's a company I'm looking at called Boston Therapeutics, they trade on the OTCQB under the ticker BTHE and they're developing a consumable, chewable tablet as a substitution to needles. They also have another product which is an after-meal supplement to reduce glucose release.
Have a look if you're really interested. Sorry for cross-promoting SUD.
Diabetes, page-2
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.8¢ |
Change
-0.005(3.08%) |
Mkt cap ! $173.5M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.5¢ | $213.8K | 1.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 703028 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 414968 | 7 |
View Market Depth
| Last trade - 11.59am 03/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |